Genetron Health to Present at Upcoming Investor Conferences

April 22, 2021 6:25 PM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

BEIJING, April 22, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that management will present and host one-on-one meetings at three upcoming investor conferences.

Details related to the management team’s participation are as follows:

Conference: UBS Virtual Healthcare SummitLocation: VirtualDates: April 28-29, 2021

Conference: Soochow Securities, “Innovative Medical Device Corporate Summit”Location: ShanghaiDates: April 30, 2021Presentation: Chief Medical Officer, Dr. Yun-Fu Hu will present on April 30, 2021

Conference: CICC Healthcare Industry Forum 2021, “Innovation Drives Growth, Quality Drives Consumption”Location: ShanghaiDates: May 18-19, 2021Presentation: Co-Founder and CEO, Sizhen Wang will present on May 18, 2021

Interested parties may request more information by contacting their sales representatives at UBS, Soochow Securities, and CICC.

About Genetron Holdings Limited

Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH) is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive oncology portfolio that covers the entire spectrum of cancer management, addressing needs and challenges from early screening, diagnosis and treatment recommendations, as well as continuous disease monitoring and care. Genetron Health also partners with global biopharmaceutical companies and offers customized services and products. For more information, please visit

Safe Harbor Statement

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as “may”, “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law.

Investor Relations ContactUS:Hoki LukHead of Investor RelationsEmail: Phone: +1 (408) 891-9255

David Deuchler, CFAManaging Director | Gilmartin GroupEmail:


Primary Logo

Source: Genetron Holdings Limited

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Globe Newswire, Press Releases

Related Entities